Magellan Health, Inc.
Magellan Health, Inc. MGLN Peers
See (MGLN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MGLN | $94.99 | N/A | N/A | 8.49 | $11.19 | N/A |
| UNH | $378.81 | -0.48% | 343.63B | 15.86 | $23.89 | +2.22% |
| ANTM | $482.58 | +2.71% | 114.59B | 18.99 | $25.41 | +1.59% |
| ELV | $416.80 | +3.02% | 94.17B | 16.21 | $25.71 | +1.59% |
| CI | $315.63 | -5.35% | 84.32B | 17.60 | $17.93 | +1.82% |
| CVS | $64.81 | -3.23% | 81.99B | 15.47 | $4.19 | +4.16% |
| CNC | $62.89 | +0.16% | 31.29B | 9.28 | $6.78 | N/A |
| HUM | $252.88 | +1.34% | 30.52B | 17.85 | $14.17 | +1.41% |
| MOH | $327.63 | +1.68% | 17.76B | 15.83 | $20.70 | N/A |
| OSCR | $16.80 | -1.81% | 3.68B | 168.00 | $0.10 | N/A |
Stock Comparison
MGLN vs UNH Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, UNH has a market cap of 343.63B. Regarding current trading prices, MGLN is priced at $94.99, while UNH trades at $378.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas UNH's P/E ratio is 15.86. In terms of profitability, MGLN's ROE is +0.00%, compared to UNH's ROE of +0.32%. Regarding short-term risk, MGLN is less volatile compared to UNH. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs ANTM Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, ANTM has a market cap of 114.59B. Regarding current trading prices, MGLN is priced at $94.99, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas ANTM's P/E ratio is 18.99. In terms of profitability, MGLN's ROE is +0.00%, compared to ANTM's ROE of +0.14%. Regarding short-term risk, MGLN is less volatile compared to ANTM. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs ELV Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, ELV has a market cap of 94.17B. Regarding current trading prices, MGLN is priced at $94.99, while ELV trades at $416.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas ELV's P/E ratio is 16.21. In terms of profitability, MGLN's ROE is +0.00%, compared to ELV's ROE of +0.14%. Regarding short-term risk, MGLN is less volatile compared to ELV. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs CI Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, CI has a market cap of 84.32B. Regarding current trading prices, MGLN is priced at $94.99, while CI trades at $315.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CI's P/E ratio is 17.60. In terms of profitability, MGLN's ROE is +0.00%, compared to CI's ROE of +0.12%. Regarding short-term risk, MGLN is less volatile compared to CI. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs CVS Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, CVS has a market cap of 81.99B. Regarding current trading prices, MGLN is priced at $94.99, while CVS trades at $64.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CVS's P/E ratio is 15.47. In terms of profitability, MGLN's ROE is +0.00%, compared to CVS's ROE of +0.07%. Regarding short-term risk, MGLN is less volatile compared to CVS. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs CNC Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, CNC has a market cap of 31.29B. Regarding current trading prices, MGLN is priced at $94.99, while CNC trades at $62.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CNC's P/E ratio is 9.28. In terms of profitability, MGLN's ROE is +0.00%, compared to CNC's ROE of +0.13%. Regarding short-term risk, MGLN is less volatile compared to CNC. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs HUM Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, HUM has a market cap of 30.52B. Regarding current trading prices, MGLN is priced at $94.99, while HUM trades at $252.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas HUM's P/E ratio is 17.85. In terms of profitability, MGLN's ROE is +0.00%, compared to HUM's ROE of +0.10%. Regarding short-term risk, MGLN is less volatile compared to HUM. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs MOH Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, MOH has a market cap of 17.76B. Regarding current trading prices, MGLN is priced at $94.99, while MOH trades at $327.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas MOH's P/E ratio is 15.83. In terms of profitability, MGLN's ROE is +0.00%, compared to MOH's ROE of +0.26%. Regarding short-term risk, MGLN is less volatile compared to MOH. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs OSCR Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, OSCR has a market cap of 3.68B. Regarding current trading prices, MGLN is priced at $94.99, while OSCR trades at $16.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas OSCR's P/E ratio is 168.00. In terms of profitability, MGLN's ROE is +0.00%, compared to OSCR's ROE of +0.02%. Regarding short-term risk, MGLN is less volatile compared to OSCR. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs ALHC Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, ALHC has a market cap of 2.95B. Regarding current trading prices, MGLN is priced at $94.99, while ALHC trades at $14.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas ALHC's P/E ratio is -31.74. In terms of profitability, MGLN's ROE is +0.00%, compared to ALHC's ROE of -0.81%. Regarding short-term risk, MGLN is less volatile compared to ALHC. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs CLOV Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, CLOV has a market cap of 1.76B. Regarding current trading prices, MGLN is priced at $94.99, while CLOV trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CLOV's P/E ratio is -38.56. In terms of profitability, MGLN's ROE is +0.00%, compared to CLOV's ROE of -0.13%. Regarding short-term risk, MGLN is less volatile compared to CLOV. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs BHG Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, BHG has a market cap of 130.51M. Regarding current trading prices, MGLN is priced at $94.99, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas BHG's P/E ratio is -0.12. In terms of profitability, MGLN's ROE is +0.00%, compared to BHG's ROE of +3.25%. Regarding short-term risk, MGLN is less volatile compared to BHG. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs BMGL Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, BMGL has a market cap of 88.29M. Regarding current trading prices, MGLN is priced at $94.99, while BMGL trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas BMGL's P/E ratio is 52.22. In terms of profitability, MGLN's ROE is +0.00%, compared to BMGL's ROE of N/A. Regarding short-term risk, MGLN is less volatile compared to BMGL. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs MRAI Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, MRAI has a market cap of 19.96M. Regarding current trading prices, MGLN is priced at $94.99, while MRAI trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas MRAI's P/E ratio is -0.46. In terms of profitability, MGLN's ROE is +0.00%, compared to MRAI's ROE of +0.93%. Regarding short-term risk, MGLN is less volatile compared to MRAI. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs NIVF Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, NIVF has a market cap of 2.33M. Regarding current trading prices, MGLN is priced at $94.99, while NIVF trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas NIVF's P/E ratio is -0.01. In terms of profitability, MGLN's ROE is +0.00%, compared to NIVF's ROE of +0.03%. Regarding short-term risk, MGLN is less volatile compared to NIVF. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.
MGLN vs IVF Comparison
MGLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at N/A. In comparison, IVF has a market cap of 2.27M. Regarding current trading prices, MGLN is priced at $94.99, while IVF trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas IVF's P/E ratio is -0.07. In terms of profitability, MGLN's ROE is +0.00%, compared to IVF's ROE of N/A. Regarding short-term risk, MGLN is less volatile compared to IVF. This indicates potentially lower risk in terms of short-term price fluctuations for MGLN.